Bioteque Corporation (TPEX:4107)
125.00
0.00 (0.00%)
At close: Dec 4, 2025
Bioteque Revenue
Bioteque had revenue of 519.26M TWD in the quarter ending September 30, 2025, a decrease of -6.15%. This brings the company's revenue in the last twelve months to 2.07B, down -0.68% year-over-year. In the year 2024, Bioteque had annual revenue of 2.07B with 6.58% growth.
Revenue (ttm)
2.07B
Revenue Growth
-0.68%
P/S Ratio
4.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.07B | 127.87M | 6.58% |
| Dec 31, 2023 | 1.94B | -65.57M | -3.26% |
| Dec 31, 2022 | 2.01B | 184.78M | 10.12% |
| Dec 31, 2021 | 1.83B | -122.17M | -6.27% |
| Dec 31, 2020 | 1.95B | 88.76M | 4.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 34.99M |
| PharmaEssentia | 13.82B |
| Heron Neutron Medical | 5.53M |
| Lotus Pharmaceutical | 18.66B |
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 42.59M |
| Center Laboratories | 1.57B |